TrialThe British journal of dermatology2019

Bone marrow transplant with post-transplant cyclophosphamide for recessive dystrophic epidermolysis bullosa expands the related donor pool and permits tolerance of nonhaematopoietic cellular grafts.

C L Ebens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.